NCT00754780View on ClinicalTrials.gov

Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

August 31, 2004

Conditions
Neurofibromatosis
Interventions
DRUG

Pirfenidone

Capsule 800 mg TID, oral

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT00754780 - Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 | Biotech Hunter | Biotech Hunter